Chromosome-specific aneusomy in carcinoma of the breast

Clinical Cancer Research

Volumn 2, Issue 5, 1996, Pages 883-888

  Persons, Diane L ^a,d   Robinson, Robert A ^b   Hsu, Ping H ^c   Seelig, Steven A ^c   Borell, Thomas J ^a   Hartmann, Lynn C ^a   Jenkins, Robert B ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c ABBOTT LABORATORIES   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOMA; CASE CONTROL STUDY; CHROMOSOME ABERRATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; ANEUPLOIDY; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED;

EID: 0030011803     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Boring, C. C., Squires, T. S., Tong, T., and Montgomery, S. Cancer statistics, 1994. CA Cancer J. Clin., 44: 7-26, 1994.
2. Mitelman, F. (ed.). Catalog of Chromosome Aberrations in Cancer, Ed. 4. New York: Wiley-Liss, Inc., 1991.
3. Trent, J. M. Cytogenetic and molecular biologic alterations in human breast cancer: a review. Breast Cancer Res. Treat., 5: 221-229, 1995.
4. Gebhart, E., Bruderlein, S., Augustus, M., Siebert, E., Feldner, J., and Schmidt, W. Cytogenetic studies on human breast carcinomas. Breast Cancer Res. Treat., 8: 125-138, 1986.
5. Lu, Y-J., Xiao, S., Yan, Y-S., Fu, S-B., Liu, Q-Z., and Li, P. Direct chromosome analysis of 50 primary breast carcinomas. Cancer Genet. Cytogenet., 69: 91-99, 1993.
6. Pandis, N., Jin, Y., Gourunova, L., Petersson, C., Bardi, G., Idvall, I., Johansson, B., Ingvar, C., Mandahl, N., Mitelman, F., and Heim, S. Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes Chromosomes & Cancer, 12: 173-185, 1995.
7. Rohen, C., Meyer-Bolte, K., Bonk, U., Ebel, T., Staats, B., Leuschner, E., Gohla, G., Caselitz, J., Bartnitzke, S., and Bullerdiek, J. Trisomy 8 and 18 as frequent clonal and single-cell aberrations in 185 primary breast carcinomas. Cancer Genet. Cytogenet., 80: 33-39, 1995.
8. Pinkel, D., Straume, T., and Gray, J. W. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc. Natl. Acad. Sci. USA, 83: 2934-2938, 1986.
9. Hopman, A. H. N., Poddighe, P. J., Smeets, A. W. G. B., Moesker, O., Beck, J. L. M., Vooijs, G. P., and Ramaekers, F. C. S. Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization. Am. J. Pathol., 135: 1105-1117, 1989.
10. Hopman, A. H. N., Moesker, O., Smeets, A. W. G. B., Pauwels, R. P. E., Vooijs, G. P., and Ramaekers, F. C. S. Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res., 51: 644-651, 1991.
11. Waldman, F. M., Carroll, P. R., Kerschmann, R., Cohen, M. B., Field, F. G., and Mayall, B. H. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res., 51: 3807-3813, 1991.
12. Arnoldus, E. P. J., Noordermeer, I. A., Peters, A. C. B., Voormolen, J. H. C., Bots, G T. A. M., Raa, P. A. K., and van der Ploeg, M. Interphase cytogenetics of brain tumors. Genes Chromosomes & Cancer, 3: 101-107, 1991.
13. Devilee, P., Thierry, R. F , Kievits, T., Kolluri, R., Hopman, A. H. N., Willard, H. F., Pearson, P. L., and Cornelisse, C. J. Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes. Cancer Res., 48: 5825-5830, 1988
14. Balazs, M., Mayall, B. H., and Waldman, F. R. Simultaneous analysis of chromosomal aneusomy and 5-bromodeoxyuridine incorporation in MCF-7 breast tumor cell line. Cancer Genet. Cytogent., 57: 93-102, 1991.
15. Persons, D. L., Hartmann, L. C., Herath, J. F., Borell, T. J., Cliby, W. A., Keeney, G. L., and Jenkins, R. B. Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas. Am. J. Pathol., 142: 733-741, 1993.
16. Hedley, D. W., Friedlander, M. L., Taylor, I. W., Rugg, C. A., and Musgrove, E. A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J. Histochem. Cytochem , 31, 1333-1335, 1983.
17. Rodgers, C. S., Hill, S M., and Hulten, M. A. Cytogenetic analysis in human breast carcinoma. I. Nine cases in the diploid range investigated using direct preparations Cancer Genet. Cytogenet., 13: 95-119, 1984.
18. Hill, S. M., Rodgers, C. S., and Hulten, M. A. Cytogenetic analysis in human breast carcinoma. II. Seven cases in the triploid/tetraploid range investigated using direct preparations. Cancer Genet. Cytogenet., 24: 45-62, 1987.
19. Gerbault-Seureau, M., Vielh, P., Zafrani, B., Salmon, R., and Dutrillaux, B. Cytogenetic study of twelve human near-diploid breast cancers with chromosomal changes. Ann. Genet., 30: 138-145, 1987.
20. Hainsworth, P. J., Raphael, K. L., Stillwell, R. G., Bennett, R. C., and Garson, O. M. Cytogenetic features of twenty-six primary breast cancers. Cancer Genet. Cytogenet., 52: 205-218, 1991.
21. Thompson, F., Emerson, J., Dalton, W., Yang, J-M., McGee, D., Villar, H., Knox, S., Massey, K , Weinstein, R., Bhattacharyya, A., and Trent, J. Clonal chromosome abnormalities in human breast carcinomas I. Twenty-eight cases with primary disease. Genes Chromosomes & Cancer., 7: 185-193, 1993.
22. Trent, J., Yang, J-M., Emerson, J., Dalton, W., McGee, D., Massey, K., Thompson, F., and Villar, H. Clonal chromosome abnormalities in human breast carcinomas II. Thirty-four cases with metastatic disease. Genes Chromosomes & Cancer., 7: 194-203, 1993.
23. Wolman, S. R., Smith, H. S., Stampfer, M., and Hackett, A. J. Growth of diploid cells from breast cancers. Cancer Genet. Cytogenet., 16: 49-64, 1985.
24. Zhang, R., Wiley, J., Howard, S. P., Meisner, L. F., and Gould, M. N. Rare clonal karyotypic variations in primary cultures of human breast carcinoma cells. Cancer Res., 49: 444-449, 1989.
25. Bullerdiek, J., Leuschner, E., Taquia, E., Bonk, U., and Bartnitzke, S. Trisomy 8 as a recurrent clonal abnormality in breast cancer? Cancer Genet. Cytogenet., 65: 64-67, 1993.
26. Rodgers, C. S., Hill, S. M., and Hulten, M. A., Cytogenetic analysis in human breast carcinoma. I. Nine cases in the diploid range investigated using direct preparations. Cancer Genet. Cytogenet., 13: 95-119, 1984.
27. Hill, S. M., Rodgers, C. S., and Hulten, M. A. Cytogenetic analysis in human breast carcinoma. II. Seven cases in the triploid/tetraploid range investigated using direct preparation. Cancer Genet. Cytogenet., 24: 45-62, 1987.
28. Devilee, P., van Vliet, M., van Sloun, P., Kuipersj-Dijkshoorn, N., Hermans, J., Pearson, P. L., and Cornelisse, C. J. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene, 6: 1705-1711, 1991.
29. Mackay, J., Elder, P. A., Porteous, D. J., Steel, C. M., Hawkins, R. A., Going, J. J., and Chetty, U. Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level. Br. J. Cancer., 58: 710-714, 1988.
30. Ali, I. U., Lidereau, R., Theillet, C., and Callahan, R. Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia. Science (Washington DC), 238: 185-188, 1987.
31. Ali, I. U., Merlo, G., Callahan, R., and Lidereau, R. The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2, and hst loci. Oncogene, 4: 89-92, 1989.
32. Adnane, J., Gaudray, P., Simon, M. P., Simony-Lafontaine, J., Jeanteur, P., and Theillet, C. Proto-oncogene amplification and human breast tumor phenotype. Oncogene, 4: 1389-1395, 1989.
33. Geleick, D., Hansjakob, M., Matter, A., Torhorst, J., and Regenass, U. Cytogenetics of breast cancer. Cancer Genet. Cytogenet., 46: 217-229, 1990.
34. Sato, T., Tanigami, A. Yamakawa, K., Akiyama, F., Kasumi, F., Sakamoto, G., and Nakamura, Y. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res., 50: 7184-7189, 1990.
35. Larsson, C., Bystrom, C., Skoog, L., Rotstein, S., and Nordenskjold, M. Genomic alterations in human breast carcinomas. Genes Chromosomes & Cancer., 2: 191-197, 1991.
36. Varley, J. M., Brammar, W. J., Lane, D. P., Swallow, J. E., Dolan, C., and Walker, R. A. Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas. Oncogene, 6: 413-421, 1991.
37. Hall, J. M., Lee, M. K., Newman, B , Morrow, J., Anderson, L., Huey, B., and King, M-C. Linkage of early-onset familial breast cancer to chromosome 17q21. Science (Washington DC), 250: 1684-1689, 1990.
38. Sato, T., Saito, H., Swenso, I., Olifant, A., Wood, C., Danner, D., Sakamoto, T., Takita, K., Kasumi, F., Mita, Y., Skolnick, M., and Nakumura, Y. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res., 52: 1643-1646, 1992.
39. Leone, A., McBride, O. W., Weston, A., Wang, M. G., Anglard, P., Cropp, C. S., Goepel, J. R., Lidereau, R., Callahan, R., Linehan, W. M., Harris, C. C., Liotta, L. A , and Steeg, P. S. Somatic allelic deletion of nm23 in human cancer. Cancer Res., 51: 2490-2493, 1991.
40. Roelink, H , Wagenaar, E., Lopes da Silva, S., and Nusse, R. Wnt-3, a gene activated by proviral insertion in mouse mammary tumors, is homologous to int-1/Wnt-1 and is normally expressed in mouse embryos and adult brain. Proc. Natl. Acad. Sci. USA, 87: 4519-4523, 1990.
41. Pandis, N., Heim, S., Bardi, G., Idvall, I., Mandahl, N., and Mitelman, F. Chromosome analysis of 20 breast carcinomas: cytogenetic multiclonality and karyotypic-pathologic correlations. Genes Chromosomes & Cancer, 6: 51-57, 1993.